clinical outcomes and patterns of failure in pineoblastoma: a 30-year single institution experience...
TRANSCRIPT
![Page 1: Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-year Single Institution Experience Benjamin Farnia, B.A. ASTRO Poster Discussion September](https://reader035.vdocuments.site/reader035/viewer/2022062518/56649e525503460f94b47cb9/html5/thumbnails/1.jpg)
Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-year Single Institution
Experience
Benjamin Farnia, B.A.ASTRO Poster Discussion
September 14, 2014
![Page 2: Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-year Single Institution Experience Benjamin Farnia, B.A. ASTRO Poster Discussion September](https://reader035.vdocuments.site/reader035/viewer/2022062518/56649e525503460f94b47cb9/html5/thumbnails/2.jpg)
Purpose
• To update outcomes and assess prognostic factors in patients with pineoblastoma who have been treated with a modern, multimodality approach, including surgery, radiation, and chemotherapy
![Page 3: Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-year Single Institution Experience Benjamin Farnia, B.A. ASTRO Poster Discussion September](https://reader035.vdocuments.site/reader035/viewer/2022062518/56649e525503460f94b47cb9/html5/thumbnails/3.jpg)
![Page 4: Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-year Single Institution Experience Benjamin Farnia, B.A. ASTRO Poster Discussion September](https://reader035.vdocuments.site/reader035/viewer/2022062518/56649e525503460f94b47cb9/html5/thumbnails/4.jpg)
![Page 5: Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-year Single Institution Experience Benjamin Farnia, B.A. ASTRO Poster Discussion September](https://reader035.vdocuments.site/reader035/viewer/2022062518/56649e525503460f94b47cb9/html5/thumbnails/5.jpg)
![Page 6: Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-year Single Institution Experience Benjamin Farnia, B.A. ASTRO Poster Discussion September](https://reader035.vdocuments.site/reader035/viewer/2022062518/56649e525503460f94b47cb9/html5/thumbnails/6.jpg)
Overall Survival
0.0
00
.25
0.5
00
.75
1.0
0P
rop
ort
ion
0 5 10 15 20 25 30Analysis Time (Years)
Median OS: 8.7 years with 2- and 5-year actuarial rates of 89.5% and 69.4%.
![Page 7: Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-year Single Institution Experience Benjamin Farnia, B.A. ASTRO Poster Discussion September](https://reader035.vdocuments.site/reader035/viewer/2022062518/56649e525503460f94b47cb9/html5/thumbnails/7.jpg)
Disease Free Survival
0.0
00
.25
0.5
00
.75
1.0
0P
rop
ortio
n
0 5 10 15 20 25 30Analysis Time (Years)
Median DFS: 10 years with 2- and 5-year actuarial rates of 84.3% and 62.6%.
![Page 8: Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-year Single Institution Experience Benjamin Farnia, B.A. ASTRO Poster Discussion September](https://reader035.vdocuments.site/reader035/viewer/2022062518/56649e525503460f94b47cb9/html5/thumbnails/8.jpg)
Additional Findings
![Page 9: Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-year Single Institution Experience Benjamin Farnia, B.A. ASTRO Poster Discussion September](https://reader035.vdocuments.site/reader035/viewer/2022062518/56649e525503460f94b47cb9/html5/thumbnails/9.jpg)
Age
• Univariate analysis failed to correlate age with OS or PFS
• Perhaps with modern treatment, pineoblastoma in children does not necessarily translate to a uniformly poor prognosis as previously thought
![Page 10: Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-year Single Institution Experience Benjamin Farnia, B.A. ASTRO Poster Discussion September](https://reader035.vdocuments.site/reader035/viewer/2022062518/56649e525503460f94b47cb9/html5/thumbnails/10.jpg)
Proton vs. Photon Radiation
• As seen in univariate analysis, no difference in survival or recurrence between patients treated with proton- and photon-based therapy
![Page 11: Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-year Single Institution Experience Benjamin Farnia, B.A. ASTRO Poster Discussion September](https://reader035.vdocuments.site/reader035/viewer/2022062518/56649e525503460f94b47cb9/html5/thumbnails/11.jpg)
Timing of Radiation
• Neoadjuvant radiation was associated with a longer disease-free survival, p=0.09
• Similar to medulloblastoma, patients who developed recurrent disease following radiation had a worse prognosis compared to patients treated with salvage radiation (numbers too small for statistical significance)
![Page 12: Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-year Single Institution Experience Benjamin Farnia, B.A. ASTRO Poster Discussion September](https://reader035.vdocuments.site/reader035/viewer/2022062518/56649e525503460f94b47cb9/html5/thumbnails/12.jpg)
Extent of Radiation Field
• Disease recurrence was more common in patients who received focal radiation initially, compared to patients who received CSI initially, p=0.04
![Page 13: Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-year Single Institution Experience Benjamin Farnia, B.A. ASTRO Poster Discussion September](https://reader035.vdocuments.site/reader035/viewer/2022062518/56649e525503460f94b47cb9/html5/thumbnails/13.jpg)
Conclusion
• Modern multimodality treatment of pineoblastoma yields a high rate of overall survival with acceptable short and long-term toxicity